Purchase this article with an account.
M Mayers, M Matli, M Okumoto, M Samy, G Smolin; Recombinant human interferon alpha D in HSV-1 recurrence in the rabbit.. Invest. Ophthalmol. Vis. Sci. 1985;26(2):237-240.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Recombinant human interferon alpha subtype D (RIFN alpha D) was effective in reducing the shedding of herpes simplex virus type-1 (HSV-1) induced by 6-hydroxydopamine iontophoresis followed by topical epinephrine application in previously infected rabbit corneas. A treatment schedule of RIFN alpha D, two drops QID was superior to one drop BID. RIFN alpha A also appeared to be effective in reducing viral shedding. Rabbits treated with RIFN alpha D during two episodes of adrenergically induced HSV-1 shedding, but not during anticipated episodes of spontaneous shedding, did not show a significant reduction in shedding of virus. Interferon was present in significantly higher concentration in tear samples following treatment with RIFN alpha D as compared with RIFN alpha A.
This PDF is available to Subscribers Only